Conference Coverage

VIDEO: Updating the immune response to nonmelanoma skin cancer


 

EXPERT ANALYSIS FROM NOAH 57

References

ASHEVILLE, N.C. – Recent advances in basic science have shown how the local immune environment in tissue surrounding nonmelanoma skin cancer compares to adjacent normal tissue.

New Mexico Health Sciences Center’s Dr. Andrew Ondo reviewed the latest research in an interview at the annual meeting of the Noah Worcester Dermatological Society. “Each step along the way is a possible target for the treatment of squamous cell carcinoma,” said Dr. Ondo, who indicated that he had no financial conflicts to disclose.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

hsplete@frontlinemedcom.com

Recommended Reading

MEK inhibitors can induce skin eruptions with distinctive duskiness
MDedge Hematology and Oncology
Handheld device illuminates possible routes of melanoma metastases
MDedge Hematology and Oncology
Teledermoscopy referrals surpass paper for managing skin cancer patients
MDedge Hematology and Oncology
Xerosis is significant risk during targeted anticancer treatments
MDedge Hematology and Oncology
Overall survival plateaus at 3 years for ipilimumab-treated melanoma patients
MDedge Hematology and Oncology
Melanoma incidence highest in Oregon, lowest in Texas in 2015
MDedge Hematology and Oncology
Laser-enhanced 5-FU scores with squamous cell, basal cell patients
MDedge Hematology and Oncology
Avoid voriconazole in transplant patients at risk for skin cancer
MDedge Hematology and Oncology
Melanoma incidence drops for U.S. children and teens
MDedge Hematology and Oncology
VIDEO: Larger lentigo maligna lesions increase risk
MDedge Hematology and Oncology